Prediction of Overall Survival for Colorectal Cancer: Establishment and Validation of a Prognostic Nomogram Based on a Competitive Endogenous RNAs Network Analysis
Wei Li,Weifang Yu,Xia Jiang,Guiqi Wang,Xiaojing Jin,Zengren Zhao,Yuegeng Liu
DOI: https://doi.org/10.2139/ssrn.3397180
2019-01-01
Abstract:Background: Competitive endogenous RNAs (ceRNAs) are a newly proposed RNA interaction mechanism that has been associated with the tumorigenesis, metastasis, diagnosis and predicting survival of various cancers. In this study, we constructed a ceRNA network in colorectal cancer (CRC). Based on the ceRNA network, we sought to develop and validate a composite clinicopathologic-genomic nomogram using The Cancer Genome Atlas (TCGA) database.Methods: To construct the ceRNA network in CRC, we analyzed the mRNA Seq, miRNA Seq data and clinical information from TCGA database. LncRNA, miRNA and mRNA signatures, based on the ceRNA network, were identified using Cox proportional hazards regression model to construct risk score as independent indicators of the prognostic value in CRC patients. After the clinical features were evaluated, a composite clinicopathologic-genomic nomogram was developed by backward stepwise selection with the Akaike information criterion (AIC) to predict the probability of 1-, 3-, and 5-years overall survival (OS). We validated the above nomogram with respect to its discrimination, calibration and clinical application.Findings: More than three thousand RNAs were picked as differentially expressed RNAs (DERNAs) (P-value <0.01 and |log2fold change (FC)|>2), including 1073 lncRNAs, 276 miRNAs and 2152 mRNAs. 121 CRC specific lncRNAs, 27 miRNAs, and 60 mRNAs were identified to construct the ceRNA network (log2fold change>2, P<0·01). Multivariate Cox proportional hazards regression analysis indicated that 5 lncRNAs (LINC00461, AL590483·1, H19, HOTAIR, and AL020995·1), 3 miRNAs (hsa-mir-187, hsa-mir-32, and hsa-mir-144), and 4 mRNAs (EREG, HAND1, FJX1, and CPA4) signatures showed a significant prognostic value for CRC. Furthermore, a nomogram integrating tumor stage, residual tumor, lncRNA, miRNA, and mRNA signature was constructed in the primary cohort, which performed well in both the primary and validation sets (C-index: 0·835 and 0·848, respectively). Decision curve analysis demonstrated the clinical usefulness of the nomogram.Interpretation: This study presents a nomogram that incorporates the CRC specific ceRNA expression profile, clinical features, and pathological factors, which demonstrate its excellent differentiation and risk stratification in predicting OS in CRC patients.Funding: The study was supported by National Natural Science Foundation of China (No.81572758), Natural Science Foundation of Hebei province (No.H2017206286), Young top-notch talent Foundation of Hebei Province Office of Education (No.BJ2018042), International science and technology cooperation program of China (No.2014DFA31150), other foundation from Hebei province (No.CY201614, zh2018002, 162777271, 20180222, 18277741D) and Spark Program of the First Hospital of Hebei Medical University. Declaration of Interest: We have no declaration of interests.